The global rise in HCC incidence is strongly and disproportionately correlated with the epidemic rise of MASLD (Ma et al., 2024
Prior authorization requirements vary
Over 18 months, about nine out of every 10,000 people in the GLP-1 group were diagnosed with ischemic optic neuropathy, compared with about six out of 10,000 in the GLT2 inhibitor group and about four out of 10,000 in the DPP4 inhibitor group
This can make it challenging for adolescents and adults with needle anxiety to start their GLP-1 weight loss journey
Why Liver Elastography
More significantly, in Gileads efforts to further convenience and reduce treatment duration (and remain competitive), Harvoni was approved in the U.S., Canada, the EU and Switzerland in 2014, and debuted at $2.1 billion in sales for the year (and a whopping $3.6 billion in 1Q15)